{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:13:05Z","timestamp":1793617985777,"version":"4.5.0"},"reference-count":39,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100006005","name":"Agence de la Biom\u00e9decine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030971","name":"Grenoble Alpes University Hospital","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030971","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>This study aimed to evaluate the impact of islet transplantation (IT) on diabetes complications, death, and cancer incidence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>This retrospective, multicenter, cohort study included patients from three IT clinical trials (intervention group) and from the French health insurance claims database Syst\u00e8me National des Donn\u00e9es de Sant\u00e9 (SNDS) (control group). Two cohorts of IT recipients were analyzed: IT recipients after kidney transplantation (IAK) and IT recipients alone (ITA). They were matched with patients living with type 1 diabetes (T1D) from the SNDS using a propensity score. The primary outcome was a composite criterion including death, dialysis, amputation, nonfatal stroke, nonfatal myocardial infarction, and transient ischemic attack. The secondary outcome was cancer. Hazard ratio (HRs) and P values were obtained using Cox proportional hazards analysis and log-rank test, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The study included 61 ITA recipients matched to 610 T1D control patients and 45 IAK recipients matched to 45 T1D control patients over a median follow-up period &amp;gt;10 years. Compared with T1D control patients, ITA and IAK recipients had a lower composite outcome risk (HR 0.39 [95% CI 0.21\u20130.71; P = 0.002] and 0.52 [0.30\u20130.88; P = 0.014], respectively) that seemed driven by reduced mortality (0.22 [0.09\u20130.54]; P &amp;lt; 0.001) for ITA and reduced dialysis (0.19 [0.07\u20130.50]; P &amp;lt; 0.001) for IAK. Both groups showed no significant changes in cancer risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>This study suggests long-term benefits of IT on diabetes-related outcomes. Furthermore, despite the use of immunosuppressive drugs following IT, we observed no significant increase in the risk of cancer. Altogether, these findings highlight a favorable risk-benefit ratio of IT in treating patients with unstable T1D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc25-0059","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T17:00:02Z","timestamp":1746637202000},"page":"1007-1015","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":18,"title":["Impact of Islet Transplantation on Diabetes Complications and Mortality in Patients Living With Type 1 Diabetes"],"prefix":"10.2337","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7445-7922","authenticated-orcid":false,"given":"Quentin","family":"Perrier","sequence":"first","affiliation":[{"name":"1University of Grenoble Alpes, INSERM U1055, Department of Pharmacy, Grenoble Alpes University Hospital, LBFA, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Jambon-Barbara","sequence":"additional","affiliation":[{"name":"2University of Grenoble Alpes, INSERM U1300, Pharmacovigilance Unit, Grenoble Alpes University Hospital, HP2, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Kessler","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orianne","family":"Villard","sequence":"additional","affiliation":[{"name":"4University of Montpellier, INSERM U1191, CNRS UMR5203, Department of Endocrinology and Diabetes, University Hospital of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Buron","sequence":"additional","affiliation":[{"name":"5University of Lyon, Department of Nephrology, Immunology and Transplantation, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Guerci","sequence":"additional","affiliation":[{"name":"6University of Lorraine, Department of Endocrinology, Diabetology and Nutrition, Brabois Adult Hospital, Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Borot","sequence":"additional","affiliation":[{"name":"7University of Besan\u00e7on, Department of Endocrinology, Besan\u00e7on University Hospital, Besan\u00e7on, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Roustit","sequence":"additional","affiliation":[{"name":"8University of Grenoble Alpes, INSERM U1300, CIC1406, Grenoble Alpes University Hospital, HP2, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterine","family":"Berishvilli","sequence":"additional","affiliation":[{"name":"9University of Geneva, Cell Isolation and Transplantation Center, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Rakotoarisoa","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[{"name":"10University of Lille, INSERM UMR 1190, Department of Endocrinology, Diabetology, Metabolism and Nutrition, University Hospital of Lille, Translational Research in Diabetes, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[{"name":"5University of Lyon, Department of Nephrology, Immunology and Transplantation, Hospices Civils de Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Renard","sequence":"additional","affiliation":[{"name":"4University of Montpellier, INSERM U1191, CNRS UMR5203, Department of Endocrinology and Diabetes, University Hospital of Montpellier, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Besch","sequence":"additional","affiliation":[{"name":"3University of Strasbourg, INSERM UMR 1260, Department of Endocrinology and Diabetology, University Hospital of Strasbourg, Regenerative Nanomedicine Federation of Translational Medicine, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Berney","sequence":"additional","affiliation":[{"name":"5University of Lyon, Department of Nephrology, Immunology and Transplantation, Hospices Civils de Lyon, Lyon, France"},{"name":"9University of Geneva, Cell Isolation and Transplantation Center, Department of Surgery, Geneva University Hospitals, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Benhamou","sequence":"additional","affiliation":[{"name":"11University of Grenoble Alpes, INSERM U1055, Department of Diabetology, Endocrinology and Nutrition, Grenoble Alpes University Hospital, LBFA, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Lablanche","sequence":"additional","affiliation":[{"name":"11University of Grenoble Alpes, INSERM U1055, Department of Diabetology, Endocrinology and Nutrition, Grenoble Alpes University Hospital, LBFA, Grenoble, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"GRAGIL Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Janbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Jouve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sabatier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Broca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Granziera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Heim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Greget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Besch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Faitot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammanuel","family":"Morelon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Thaunat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Badet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Thivolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Peloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Henri","family":"Wassmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Berishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lebreton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Parnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Pernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Tauveron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Melki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cattan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Noelle","family":"Peraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Armanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoin","family":"Durrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Guerci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"2025052014523985000_B1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"2025052014523985000_B2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ajt.13458","article-title":"Long-term follow-up of the Edmonton protocol of islet transplantation in the United States","volume":"16","author":"Brennan","year":"2016","journal-title":"Am J Transplant"},{"key":"2025052014523985000_B4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.2337\/dc20-er05","article-title":"Erratum. Ten-year outcome of islet\u00a0alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study. Diabetes Care 2019;42:2042-2049","volume":"43","author":"Vantyghem","year":"2020","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B5","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1111\/ajt.16637","article-title":"Ten-year outcomes of islet transplantation in patients with type 1 diabetes: data from the Swiss-French GRAGIL Network","volume":"21","author":"Lablanche","year":"2021","journal-title":"Am J Transplant"},{"key":"2025052014523985000_B6","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.diabet.2018.07.006","article-title":"Indications for islet or pancreatic transplantation: statement of the TREPID Working Group on behalf of the Soci\u00e9t\u00e9 francophone du diab\u00e8te (SFD), Soci\u00e9t\u00e9 francaise d\u2019endocrinologie (SFE), Soci\u00e9t\u00e9 francophone de transplantation (SFT) and Soci\u00e9t\u00e9 fran\u00e7aise de n\u00e9phrologie-dialyse-transplantation (SFNDT)","volume":"45","author":"Wojtusciszyn","year":"2019","journal-title":"Diabetes Metab"},{"key":"2025052014523985000_B7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2213-8587(23)00082-7","article-title":"Association between primary graft function and 5-year outcomes of islet\u00a0allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry","volume":"11","author":"Chetboun","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025052014523985000_B8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025052014523985000_B9","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc20-2458","article-title":"Survival after islet transplantation in subjects with type 1 diabetes: twenty-year follow-up","volume":"44","author":"Lemos","year":"2021","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/ajt.16174","article-title":"Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes","volume":"21","author":"Markmann","year":"2021","journal-title":"Am J Transplant"},{"key":"2025052014523985000_B11","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/dc21-2688","article-title":"Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the Clinical Islet Transplantation Consortium: the CIT-08 study","volume":"45","author":"Rickels","year":"2022","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.2337\/diacare.28.6.1358","article-title":"Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients","volume":"28","author":"Fiorina","year":"2005","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2337\/diacare.28.6.1303","article-title":"Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation","volume":"28","author":"Fiorina","year":"2005","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S2213-8587(24)00241-9","article-title":"Islet-after-kidney transplantation versus kidney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France","volume":"12","author":"Maanaoui","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025052014523985000_B15","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"key":"2025052014523985000_B16","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/TP.0b013e318230c236","article-title":"Impact of the number of infusions on 2-year results of islet-after-kidney transplantation in the GRAGIL network","volume":"92","author":"Borot","year":"2011","journal-title":"Transplantation"},{"key":"2025052014523985000_B17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.tp.0000268511.64428.d8","article-title":"Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial","volume":"84","author":"Badet","year":"2007","journal-title":"Transplantation"},{"key":"2025052014523985000_B18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-8587(18)30078-0","article-title":"Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial","volume":"6","author":"Lablanche","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025052014523985000_B19","doi-asserted-by":"crossref","first-page":"100158","DOI":"10.1016\/j.lanepe.2021.100158","article-title":"Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people","volume":"8","author":"Semenzato","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"2025052014523985000_B20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/ard-2022-222824","article-title":"Risk of major adverse cardiovascular and venous thromboembolism events in patients with rheumatoid arthritis exposed to JAK inhibitors versus adalimumab: a nationwide cohort study","volume":"82","author":"Hoisnard","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2025052014523985000_B21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/bjd\/ljad248","article-title":"Persistence of second-line biologics in psoriasis after first-line biologic failure: a nationwide cohort study from the French health insurance database (SNDS)","volume":"189","author":"Marcombes","year":"2023","journal-title":"Br J Dermatol"},{"key":"2025052014523985000_B22","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1160\/TH16-05-0403","article-title":"Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis","volume":"116","author":"Lip","year":"2016","journal-title":"Thromb Haemost"},{"key":"2025052014523985000_B23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jdi.13128","article-title":"Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: an observational cohort study","volume":"11","author":"Nakamura","year":"2020","journal-title":"J Diabetes Investig"},{"key":"2025052014523985000_B24","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"2025052014523985000_B25","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-016-3884-9","article-title":"Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals","volume":"59","author":"Carstensen","year":"2016","journal-title":"Diabetologia"},{"key":"2025052014523985000_B26","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.2337\/dc15-0094","article-title":"Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL Network","volume":"38","author":"Lablanche","year":"2015","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B27","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/TP.0000000000000458","article-title":"Impact of procedure-related complications on long-term islet transplantation outcome","volume":"99","author":"Caiazzo","year":"2015","journal-title":"Transplantation"},{"key":"2025052014523985000_B28","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.2337\/dc16-1093","article-title":"Ten years of preserved kidney function after islet transplant graft failure","volume":"39","author":"Peixoto","year":"2016","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B29","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.tp.0000994560.00903.2c","article-title":"Islet transplantation versus insulin alone in type 1 diabetic kidney transplant recipients: a French nationwide study on behalf of the TREPID group","volume":"107","author":"Maanaoui","year":"2023","journal-title":"Transplantation"},{"key":"2025052014523985000_B30","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1681\/ASN.2008090998","article-title":"Association of CKD and cancer risk in older people","volume":"20","author":"Wong","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025052014523985000_B31","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"2025052014523985000_B32","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/dc12-0679","article-title":"Reduction in carotid intima-media thickness after pancreatic islet transplantation in patients with type 1 diabetes","volume":"36","author":"Danielson","year":"2013","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B33","doi-asserted-by":"crossref","first-page":"e13059","DOI":"10.1111\/ctr.13059","article-title":"Coronary artery calcium may stabilize following islet cell transplantation in patients with type 1 diabetes","volume":"31","author":"Madrigal","year":"2017","journal-title":"Clin Transplant"},{"key":"2025052014523985000_B34","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/cvr\/cvab264","article-title":"Risk factors profile of young and older patients with myocardial infarction","volume":"118","author":"Sagris","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2025052014523985000_B35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/dom.14654","article-title":"The beneficial effects of closed-loop insulin delivery in patients with highly unstable type 1 diabetes eligible for islet transplantation are maintained over 6 months: an extension study of the DBLHU-WP10 trial","volume":"24","author":"Benhamou","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"2025052014523985000_B36","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.2337\/dc23-0685","article-title":"Safety and efficacy of sustained automated insulin delivery compared with sensor and pump therapy in adults with Type 1 diabetes at high risk for hypoglycemia: a randomized controlled trial","volume":"46","author":"Renard","year":"2023","journal-title":"Diabetes Care"},{"key":"2025052014523985000_B37","doi-asserted-by":"crossref","first-page":"e013434","DOI":"10.1136\/bmjopen-2016-013434","article-title":"Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol","volume":"7","author":"Lablanche","year":"2017","journal-title":"BMJ Open"},{"key":"2025052014523985000_B38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-8587(24)00240-7","article-title":"Closed-loop systems: a bridge to cell therapy for type 1 diabetes?","volume":"12","author":"Hussain","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025052014523985000_B39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/CLEP.S242097","article-title":"Synthetic and external controls in clinical trials - a primer for researchers","volume":"12","author":"Thorlund","year":"2020","journal-title":"Clin Epidemiol"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/48\/6\/1007\/804106\/dc250059.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/48\/6\/1007\/804106\/dc250059.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T18:52:50Z","timestamp":1747767170000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/48\/6\/1007\/158141\/Impact-of-Islet-Transplantation-on-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,17]]},"published-print":{"date-parts":[[2025,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc25-0059","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}